Series Introduction: Replication-selective microbiological agents: fighting cancer with targeted germ warfare
Open Access
- 1 April 2000
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (7) , 837-839
- https://doi.org/10.1172/jci9761
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tumor-targeted Salmonella as a novel anticancer vector.1997
- ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsNature Medicine, 1997
- In situ cytokine gene transfection using vaccinia virus vectors.1996
- Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomasNature Medicine, 1995
- The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.1991
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976
- VIRUSES IN THE TREATMENT OF CANCERThe Lancet, 1970
- Studies on the use of viruses in the treatment of carcinoma of the cervixCancer, 1956
- THE INFLUENCE OF COMPLICATING DISEASES UPON LEUKÆMIA.*The Lancet Healthy Longevity, 1904
- THE TREATMENT OF MALIGNAT TUMORS BY REPEATED INOCULATIONS OF ERYSIPELASThe Lancet Healthy Longevity, 1893